1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Cardinal Health completed a $1 billion public offering of two note series, $600 million due 2030 and $400 million due 2035, with proceeds intended to fund part of the price of its proposed Solaris Health acquisition. If the deal is not completed by the End Date, or the company decides not to pursue it, the notes must be redeemed at 101% of principal plus accrued interest.
$600 million of 4.500% notes due 2030 and $400 million of 5.150% notes due 2035 were sold on August 27, 2025.
Net proceeds are intended to fund part of the consideration and fees for the proposed Solaris Health acquisition.
The acquisition must close by the later of August 12, 2026 or a later extended date, or the notes face special mandatory redemption at 101% of principal plus accrued interest.
Proceeds will not be placed in escrow and no security interest is required.
CooperCompanies reported fiscal third-quarter 2025 results for the period ended July 31, 2025, with revenue up 6% to $1,060.3 million and non-GAAP diluted EPS up 15% to $1.10, while GAAP diluted EPS fell 6% to $0.49. The company raised its fiscal 2025 non-GAAP diluted EPS guidance to $4.08 to $4.12, and CEO Al White said revenues were below expectations and that the company expects improving revenue in the fourth quarter and fiscal 2026. For shareholders, the decline in GAAP earnings and charges tied to a CooperSurgical product line exit sit alongside the higher adjusted earnings outlook.
Revenue of $1,060.3 million, up 6% year over year and up 2% organically; CooperVision revenue was $718.4 million and CooperSurgical revenue was $341.9 million.
GAAP diluted EPS was $0.49, down from $0.52; non-GAAP diluted EPS was $1.10, up from $0.96.
Fiscal 2025 guidance: non-GAAP diluted EPS of $4.08 to $4.12 and total revenue of $4,076 million to $4,096 million.
Repurchased $52.1 million of common stock in the quarter, with $163.6 million of remaining program availability.
Five Below reported second-quarter fiscal 2025 net sales of $1,026.8 million, up 23.7%, and GAAP diluted earnings per share of $0.77, up from $0.60 a year earlier. The company also raised its full-year 2025 sales and earnings per share guidance, which points to higher expected results for shareholders.
Q2 net sales were $1,026.8 million, up 23.7%, with comparable sales up 12.4%
Q2 GAAP diluted EPS was $0.77 versus $0.60; adjusted diluted EPS was $0.81 versus $0.54
Full-year 2025 net sales are now expected at $4.44 billion to $4.52 billion, with diluted EPS of $4.56 to $4.96
Third-quarter 2025 net sales are expected at $950 million to $970 million, with diluted EPS of $0.09 to $0.21
Timken appointed Lucian Boldea, most recently CEO of Honeywell's Industrial Automation unit, as President and CEO effective September 1, 2025, and also to its board, which will grow from twelve to thirteen directors. Richard G. Kyle, who has been interim CEO, will retire from that role and stay on as an employee advisor through November 14, 2025. The filing lists large sign-on and special equity awards, which shareholders may weigh as part of the leadership transition.
Boldea's base salary is $1,100,000 per year, with a short-term incentive target of 125% of base salary.
Sign-on package includes a $1,500,000 cash payment and RSUs with a target grant value of approximately $6,037,500, plus a $7,000,000 Special Grant.
Kyle will remain principal executive officer until the Form 10-Q for the period ended September 30, 2025 is filed, then Boldea assumes the role.
Boldea's severance agreement provides two times base salary and incentive pay before a change in control, and three times within two years after one.
Pure Storage reported second-quarter fiscal 2026 results for the quarter ended August 3, 2025, with revenue of $861.0 million, up 13% year-over-year, and net income of $47.1 million, or $0.14 per diluted share. The company raised its full-year fiscal 2026 revenue and non-GAAP operating income guidance, which signals higher expected sales and profit for shareholders, although GAAP operating income fell sharply from a year earlier.
Revenue of $861.0 million, up 13% year-over-year; subscription services revenue of $414.7 million, up 15%.
GAAP operating income of $4.9 million, compared with $24.9 million a year earlier; non-GAAP operating income of $130.0 million.
Net income of $47.1 million, or $0.14 per diluted share, compared with $35.7 million, or $0.10 per diluted share, a year earlier.
Fiscal 2026 revenue guidance raised to $3.60 billion to $3.63 billion from $3.515 billion; non-GAAP operating income guidance raised to $605 million to $625 million from $595 million.
Agilent reported third-quarter fiscal 2025 revenue of $1.74 billion, up 10.1% reported and 6.1% on a core basis, and GAAP EPS of $1.18, up 22% from a year earlier. Non-GAAP EPS was $1.37, up 4%, and the company revised its full-year revenue outlook to $6.91 billion to $6.93 billion with non-GAAP EPS of $5.56 to $5.59. For shareholders, the filing shows higher revenue and profit and a revised full-year and fourth-quarter outlook.
Q3 revenue of $1.74 billion for the quarter ended July 31, 2025, up 10.1% reported and 6.1% core versus Q3 2024
GAAP EPS of $1.18 versus $0.97 a year earlier; non-GAAP EPS of $1.37 versus $1.32
Full-year fiscal 2025 revenue outlook of $6.91 billion to $6.93 billion; non-GAAP EPS of $5.56 to $5.59
Q4 revenue outlook of $1.822 billion to $1.842 billion; non-GAAP EPS of $1.57 to $1.60
BILL reported fourth-quarter and fiscal 2025 results for the period ended June 30, 2025, with total revenue up 12% in the quarter and 13% for the full year, and its board authorized up to $300 million in share repurchases. The company posted a fourth-quarter GAAP net loss of $7.1 million, compared with net income of $7.6 million a year earlier, while full-year GAAP net income was $23.8 million, compared with a net loss of $28.9 million. Shareholders should note that the repurchase program does not obligate the company to buy any specific amount of stock, and fiscal 2026 total revenue guidance is $1,589.5 million to $1,629.5 million.
Q4 fiscal 2025 total revenue was $383.3 million, up 12% year-over-year; core revenue was $345.9 million, up 15%.
Q4 GAAP net loss was $7.1 million, or $0.07 per share, versus net income of $7.6 million in Q4 fiscal 2024; non-GAAP operating income was $56.4 million, down 6%.
Fiscal 2025 total revenue was $1,462.6 million, up 13%, and GAAP net income was $23.8 million versus a net loss of $28.9 million in fiscal 2024.
The $300 million share repurchase program has no set end date; the company expects to fund it with existing cash. Fiscal 2026 non-GAAP net income per diluted share guidance is $2.00 to $2.20.
Nutanix reported fourth-quarter fiscal 2025 revenue of $653.3 million, up 19% from a year earlier, and GAAP net income of $38.7 million, compared with a net loss of $126.1 million in the prior-year quarter. The company also issued a separate release saying its Board authorized repurchases of up to $350 million of Class A common stock, and it gave fiscal 2026 and first-quarter outlooks.
Q4 fiscal 2025 revenue was $653.3 million, up 19% from $548.0 million; fiscal 2025 revenue was $2.54 billion, up 18%.
Q4 GAAP net income was $38.7 million, or $0.13 per diluted share, versus a net loss of $126.1 million, or $(0.51) per share, a year earlier.
Fiscal 2025 free cash flow was $750.2 million; fiscal 2026 free cash flow outlook is $790 million to $830 million.
Board authorized repurchases of up to $350 million of Class A common stock; first-quarter fiscal 2026 revenue outlook is $670 million to $680 million.
REX American Resources reported fiscal second-quarter 2025 net sales and revenue of $158.6 million, up from $148.2 million a year earlier, but net income attributable to REX shareholders fell to $7.1 million from $12.4 million and diluted earnings per share fell to $0.43 from $0.70. The board also declared a 2-for-1 stock split, payable September 15, 2025 to holders of record on September 8, 2025, which would roughly double the outstanding share count to 33,057,574 shares.
Net sales and revenue rose to $158.6 million from $148.2 million, which the company attributes mainly to higher volumes despite lower ethanol and distillers grain prices.
Gross profit fell to $14.3 million from $19.8 million, and diluted EPS fell to $0.43 from $0.70.
The 2-for-1 stock split is a 100% stock dividend payable September 15, 2025 to shareholders of record on September 8, 2025.
Cash, cash equivalents and short-term investments totaled $310.5 million at July 31, 2025, with no bank debt.
Williams-Sonoma reported second-quarter 2025 results for the period ended August 3, 2025, with net revenues of $1.84 billion, diluted EPS of $2.00 versus $1.67 a year earlier, and an operating margin of 17.9%. The company raised its fiscal 2025 net revenue outlook but reiterated its operating margin guidance, noting that higher tariff costs will pressure the flow-through of higher revenue.
Net revenues of $1.84 billion versus $1.79 billion in the second quarter of 2024; comparable brand revenue rose 3.7%.
Diluted EPS of $2.00, up 19.8% from $1.67; operating income of $328 million at a 17.9% margin.
Fiscal 2025 net revenue growth outlook raised to +0.5% to +3.5%; operating margin outlook reiterated at 17.4% to 17.8%.
Returned $280 million to stockholders in the quarter, including $199 million in stock repurchases and $81 million in dividends.
J.M. Smucker reported a fiscal 2026 first-quarter net loss of $0.41 per diluted share, compared with net income of $1.74 per share a year earlier, while net sales fell 1% to $2.1 billion. Adjusted earnings per share fell 22% to $1.90, and operating cash flow was negative $10.6 million. The company raised its full-year net sales growth outlook to 3.0% to 5.0% and its free cash flow outlook to $975.0 million, but kept its adjusted earnings per share guidance at $8.50 to $9.50.
Net sales were $2.1 billion, down $11.8 million or 1%; excluding divestitures and currency, net sales rose 2%.
Net loss per diluted share was $0.41, versus net income of $1.74 per share a year earlier; GAAP operating income fell 87% to $45.6 million.
Adjusted earnings per share were $1.90, down 22% from $2.44.
FY2026 net sales growth outlook raised to 3.0% to 5.0% from 2.0% to 4.0%; adjusted earnings per share guidance unchanged at $8.50 to $9.50; free cash flow outlook raised to $975.0 million from $875.0 million.
Kohl's reported second-quarter fiscal 2025 net sales down 5.1% to $3.3 billion, with comparable sales down 4.2%. GAAP diluted EPS was $1.35, helped by a $129 million gain on a credit card interchange fee lawsuit settlement, while adjusted diluted EPS was $0.56 versus $0.59 a year earlier. The company raised its full-year 2025 outlook, and its board reduced the annual cash dividend to $0.50 per share to give the company more balance sheet flexibility.
Net sales fell 5.1% to $3.3 billion; gross margin rose 28 basis points to 39.9%
GAAP diluted EPS of $1.35 versus $0.59 a year earlier; adjusted diluted EPS of $0.56 versus $0.59
Full-year 2025 adjusted diluted EPS guidance of $0.50 to $0.80; net sales expected to decline 5% to 6%
Quarterly dividend of $0.125 per share payable September 24, 2025; presentation says annual dividend reduced to $0.50 per share
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.